The aggregate value of cancer screenings in the United States: full potential value and value considering adherence
Abstract Background Although cancer mortality has been decreasing since 1991, many cancers are still not detected until later stages with poorer outcomes. Screening for early-stage cancer can save lives because treatments are generally more effective at earlier than later stages of disease. Evidence...
Main Authors: | Tomas J. Philipson, Troy Durie, Ze Cong, A. Mark Fendrick |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12913-023-09738-4 |
Similar Items
-
Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
by: A. Mark Fendrick, et al.
Published: (2022-04-01) -
Cancer Screening: Present Recommendations, the Development of Multi-Cancer Early Development Tests, and the Prospect of Universal Cancer Screening
by: Laurenția Nicoleta Galeș, et al.
Published: (2024-03-01) -
Breast, Colorectal, Lung, Prostate, and Cervical Cancer Screening Prevalence in a Large Commercial and Medicare Advantage Plan, 2008–2020
by: Ashley Kim, et al.
Published: (2022-12-01) -
Lung Cancer Screening in Greece: A Modelling Study to Estimate the Impact on Lung Cancer Life Years
by: Kyriakos Souliotis, et al.
Published: (2022-11-01) -
Adherence to Cancer Screening Guidelines and Predictors of Improvement Among Participants in the Kansas State Employee Wellness Program
by: Siu-kuen Azor Hui, PhD, MSPH, et al.
Published: (2013-07-01)